TNGX

Tango Therapeutics is a biotechnology company developing precision oncology therapies that target cancer vulnerabilities to deliver durable clinical benefit. The company focuses on synthetic lethality and tumor immunology approaches, creating treatments designed to exploit specific genetic alterations in cancer cells. Tango utilizes its proprietary discovery platform to identify novel drug targets and advance clinical-stage programs.